Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.

Algeciras-Schimnich A, Milosevic D, McIver B, Flynn H, Reddi HV, Eberhardt NL, Grebe SK.

Clin Chem. 2010 Mar;56(3):391-8. doi: 10.1373/clinchem.2009.134015. Epub 2010 Jan 7.

2.

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.

Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, Hegedüs L, Paschke R, Eszlinger M.

Thyroid. 2012 Oct;22(10):1025-30. doi: 10.1089/thy.2011.0391.

3.

Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.

Klemke M, Drieschner N, Belge G, Burchardt K, Junker K, Bullerdiek J.

Genes Chromosomes Cancer. 2012 Apr;51(4):402-8. doi: 10.1002/gcc.21925. Epub 2011 Dec 16.

PMID:
22179975
4.

Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.

Giordano TJ, Au AY, Kuick R, Thomas DG, Rhodes DR, Wilhelm KG Jr, Vinco M, Misek DE, Sanders D, Zhu Z, Ciampi R, Hanash S, Chinnaiyan A, Clifton-Bligh RJ, Robinson BG, Nikiforov YE, Koenig RJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1983-93.

5.

Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.

Chia WK, Sharifah NA, Reena RM, Zubaidah Z, Clarence-Ko CH, Rohaizak M, Naqiyah I, Srijit D, Hisham AN, Asmiati A, Rafie MK.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):7-13. doi: 10.1016/j.cancergencyto.2009.08.001.

PMID:
19963130
6.

Low frequency of PAX8-PPARγ rearrangement in follicular thyroid carcinomas in Japanese patients.

Mochizuki K, Kondo T, Oishi N, Tahara I, Inoue T, Kasai K, Nakazawa T, Okamoto T, Shibata N, Katoh R.

Pathol Int. 2015 May;65(5):250-3. doi: 10.1111/pin.12270. Epub 2015 Feb 23.

PMID:
25708358
7.

PAX8-PPARgamma oncogene in follicular thyroid tumors: RT-PCR and immunohistochemical analyses.

Pauzar B, Karner I, Glavas-Obrovac L, Stefanić M, Dmitrović B.

Coll Antropol. 2012 Nov;36 Suppl 2:79-82.

PMID:
23397760
8.

Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?

Hibi Y, Nagaya T, Kambe F, Imai T, Funahashi H, Nakao A, Seo H.

Endocr J. 2004 Jun;51(3):361-6.

9.

Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.

Bongiovanni M, Molinari F, Eszlinger M, Paschke R, Barizzi J, Merlo E, Giovanella L, Fasolini F, Cattaneo F, Ramelli F, Mazzucchelli L, Frattini M.

Cytopathology. 2015 Oct;26(5):288-96. doi: 10.1111/cyt.12226. Epub 2014 Dec 8.

PMID:
25487739
10.

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Sep;24(9):1369-74. doi: 10.1089/thy.2014.0067. Epub 2014 Jul 16.

11.

Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.

Caria P, Frau DV, Dettori T, Boi F, Lai ML, Mariotti S, Vanni R.

Cancer Cytopathol. 2014 May;122(5):377-85. doi: 10.1002/cncy.21397. Epub 2014 Feb 7.

12.

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.

Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V.

J Clin Endocrinol Metab. 2002 Aug;87(8):3947-52.

PMID:
12161538
13.

Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.

Lado-Abeal J, Celestino R, Bravo SB, Garcia-Rendueles ME, de la Calzada J, Castro I, Castro P, Espadinha C, Palos F, Soares P, Alvarez CV, Sobrinho-Simões M, Cameselle-Teijeiro J.

Endocr Relat Cancer. 2010 Jun 3;17(3):599-610. doi: 10.1677/ERC-09-0069. Print 2010 Sep.

14.

PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.

Eur J Endocrinol. 2004 Sep;151(3):367-74.

15.

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M.

J Clin Endocrinol Metab. 2006 Jan;91(1):213-20. Epub 2005 Oct 11.

PMID:
16219715
16.

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

Foukakis T, Au AY, Wallin G, Geli J, Forsberg L, Clifton-Bligh R, Robinson BG, Lui WO, Zedenius J, Larsson C.

J Clin Endocrinol Metab. 2006 Mar;91(3):1143-9. Epub 2005 Dec 13.

PMID:
16352687
17.

Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.

Zhang Y, Yu J, Lee C, Xu B, Sartor MA, Koenig RJ.

Oncotarget. 2015 Dec 1;6(38):40418-32. doi: 10.18632/oncotarget.6340.

18.

A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.

Castro P, Roque L, Magalhães J, Sobrinho-Simões M.

Int J Surg Pathol. 2005 Jul;13(3):235-8.

PMID:
16086077
19.

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE.

J Clin Endocrinol Metab. 2003 May;88(5):2318-26.

PMID:
12727991
20.

Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.

Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG.

J Clin Endocrinol Metab. 2003 Jan;88(1):354-7.

PMID:
12519876

Supplemental Content

Support Center